Promotion Spillovers: Drug Detailing in Combination Therapy

References

• Balachander S, Ghose S (2003) Reciprocal spillover effects: A strategic benefit of brand extensions. J. Marketing 67(1):4–13.Crossref, Google Scholar
• Berndt ER, Bui LT, Lucking-Reiley DH, Urban GL (1997) The roles of marketing, product quality, and price competition in the growth and composition of the U.S. antiulcer drug industry. Bresnahan TF, Gordon RJ, eds. The Economics of New Goods (University of Chicago Press, Chicago), 277–322.Google Scholar
• Camacho N, Donkers B, Stremersch S (2011) Predictably non-Bayesian: Quantifying salience effects in physician learning about drug quality. Marketing Sci. 30(2):305–320.Link, Google Scholar
• Chan T, Narasimhan C, Xie Y (2013) Treatment effectiveness and side effects: A model of physician learning. Management Sci. 59(6):1309–1325.Link, Google Scholar
• Ching A (2010) A dynamic oligopoly structural model for the prescription drug market after patent expiration. Internat. Econom. Rev. 51(4):1175–1207.Crossref, Google Scholar
• Ching A, Ishihara M (2010) The effects of detailing on prescribing decisions under quality uncertainty. Quant. Marketing Econom. 8(2):123–165.Crossref, Google Scholar
• Ching A, Ishihara M (2012) Measuring the informative and persuasive roles of detailing on prescribing decisions. Management Sci. 58(7):1374–1387.Link, Google Scholar
• Chintagunta PK, Desiraju R (2005) Strategic pricing and detailing behavior in international markets. Marketing Sci. 24(1):67–80.Link, Google Scholar
• Chintagunta PK, Goettler RL, Kim M (2012) New drug diffusion when forward-looking physicians learn from patient feedback and detailing. J. Marketing Res. 49(6):807–821.Crossref, Google Scholar
• Chressanthis GA, Khedkar P, Jain N, Poddar P, Seiders MG (2012) Can access limits on sales representatives to physicians affect clinical prescription decisions? A study of recent events with diabetes and lipid drugs. J. Clinical Hypertension 14(7):435–446.Crossref, Google Scholar
• Chressanthis GA, Sfekas A, Khedkar P, Jain N, Poddar P (2014) Determinants of pharmaceutical sales representative access limits to physicians. J. Medical Marketing 14(4):220–243.Crossref, Google Scholar
• Dong X, Chintagunta PK, Manchanda P (2011) A new multivariate count data model to study multi-category physician prescription behavior. Quant. Marketing Econom. 9:301–337.Crossref, Google Scholar
• Dong X, Manchanda P, Chintagunta PK (2009) Quantifying the benefits of individual level targeting in the presence of firm strategic behavior. J. Marketing Res. 46:207–221.Crossref, Google Scholar
• Dubé JP, Hitsch GJ, Manchanda P (2005) An empirical model of advertising dynamics. Quant. Marketing Econom. 3:107–144.Crossref, Google Scholar
• Erdem T, Sun B (2002) An empirical investigation of the spillover effects of advertising and sales promotions in umbrella branding. J. Marketing Res. 39:408–420.Crossref, Google Scholar
• Evans D (2009) Negotiating a fair price for the Norvir tablet. POZ (June 23), https://www.poz.com/article/hiv-norvir-price-16839-5032.Google Scholar
• Feit EM, Wang P, Bradow E, Fader P (2013) Fusing aggregate and disaggregate data with an application to multiplatform media consumption. J. Marketing Res. 50:348–364.Crossref, Google Scholar
• Gentzkow M (2007) Valuing new goods in a model with complementarity: Online newspapers. Amer. Econom. Rev. 97(3):713–744.Crossref, Google Scholar
• Gönül F, Franklin C, Petrova E, Srinivasan K (2001) Promotion of prescription drugs and its impact on physicians’ choice behavior. J. Marketing 65(3):79–90.Crossref, Google Scholar
• Heckman JJ (1981) The incidental parameters problem and the problem of initial conditions in estimating a discrete time-discrete data stochastic process. Manski CF, McFadden D, eds. Structural Analysis of Discrete Data with Applications (MIT Press, Cambridge, MA), 179–195.Google Scholar
• Hendel I, Nevo A (2006) Measuring the implications of sales and consumer inventory behavior. Econometrica 74(6):1637–1673.Crossref, Google Scholar
• Janakiraman R, Dutta S, Sismeiro C, Stern P (2008) Physicians’ persistence and its implications for their response to promotion of prescription drugs. Management Sci. 54(6):1080–1093.Link, Google Scholar
• Kamakura WA, Russell G (1989) A probabilistic choice model for market segmentation and elasticity structure. J. Marketing Res. 26:379–390.Crossref, Google Scholar
• Kass RE, Raftery AE (1995) Bayes factors. J. Amer. Statist. Assoc. 90(430):773–795.Crossref, Google Scholar
• Kumar V, Sriram S, Luo A, Chintagunta PK (2011) Assessing the effect of marketing investments in a business marketing context. Marketing Sci. 30(5):924–940.Link, Google Scholar
• Larkin I, Ang D, Avorn J, Kesselheim AS (2014) Restrictions on pharmaceutical detailing reduced off-label prescribing of antidepressants and antipsychotics in children. Health Affairs 33(6):1014–1023.Crossref, Google Scholar
• Lewis R, Nguyen D (2015) Display advertising’s competitive spillovers to consumer search. Quant. Marketing Econom. 13(2):93–115.Crossref, Google Scholar
• Liu H, Chintagunta PK, Zhu T (2010) Complementarities and the demand for home broadband Internet services. Marketing Sci. 29(4):701–720.Link, Google Scholar
• Liu Q, Steenburgh TJ, Gupta S (2015) The cross attributes flexible substitution logit: Uncovering category expansion and share impacts of marketing instruments. Marketing Sci. 34(1):144–159.Link, Google Scholar
• Liu Q, Gupta S, Venkataraman S, Liu H (2016) An empirical model of drug detailing: Dynamic competition and policy implications. Management Sci. 62(8):2321–2340.Link, Google Scholar
• Llopart M, Navas E, Pastor C, Casanueva A (2012) Promoting Medical Products Globally: Handbook of Pharma and MedTech Compliance (Spain). Baker and McKenzie, Chicago.Google Scholar
• Ma Y, Seetharaman PB, Narasimhan C (2012) Modeling dependencies in brand choice outcomes across complementary categories. J. Retailing 88:47–62.Crossref, Google Scholar
• Mailath GJ, Samuelson L (2006) Repeated Games and Reputations: Long-Run Relationships (Oxford University Press, New York).Crossref, Google Scholar
• Manchanda P, Chintagunta PK (2004) Responsiveness of physician prescription behavior to salesforce effort: An individual level analysis. Marketing Lett. 15(2–3):129–145.Crossref, Google Scholar
• Manchanda P, Honka E (2005) The effects and role of direct-to-physician marketing in the pharmaceutical industry: An integrative review. Yale J. Health Policy, Law Ethics 5(2):Article 8.Google Scholar
• Manchanda P, Ansari A, Gupta S (1999) The “shopping basket”: A model for multicategory purchase incidence decisions. Marketing Sci. 18(2):95–114.Link, Google Scholar
• Manchanda P, Rossi P, Chintagunta PK (2004) Response modeling with nonrandom marketing-mix variables. J. Marketing Res. 41(4):467–478.Crossref, Google Scholar
• McFadden D, Train K (2000) Mixed MNL models for discrete response. J. Appl. Econometrics 15(5):447–470.Crossref, Google Scholar
• Mizik N, Jacobson R (2004) Are physicians “easy marks”? Quantifying the effects of detailing and sampling on new prescriptions. Management Sci. 50(12):1704–1715.Link, Google Scholar
• Montoya R, Netzer O, Jedidi K (2010) Dynamic allocation of pharmaceutical detailing and sampling for long-term profitability. Marketing Sci. 29(5):909–924.Link, Google Scholar
• Naik P, Raman K, Winer RS (2005) Planning marketing-mix strategies in the presence of interaction effects. Marketing Sci. 24(1):25–34.Link, Google Scholar
• Narayanan S, Manchanda P (2009) Heterogeneous learning and the targeting of marketing communication for new products. Marketing Sci. 28(3):424–441.Link, Google Scholar
• Narayanan S, Desiraju R, Chintagunta PK (2004) Return on investment implications for pharmaceutical promotional expenditures: The role of marketing-mix interactions. J. Marketing 68:90–105.Crossref, Google Scholar
• Narayanan S, Manchanda P, Chintagunta PK (2005) Temporal differences in the role of marketing communication in new product categories. J. Marketing Res. 42(3):278–290.Crossref, Google Scholar
• Roberts GO, Sahu SK (1997) Updating schemes, correlation structure, blocking and parameterization for the Gibbs Sampler. J. Royal Statist. Soc.: Ser. B (Statist. Methodology) 59(2):291–317.Crossref, Google Scholar
• Rossi PE, Allenby GM, McCulloch R (2012) Bayesian Statistics and Marketing (Wiley, New York).Google Scholar
• Royle JA, Chandler RB, Sollmann R, Gardner B (2013) Spatial Capture-Recapture (Academic Press, Waltham, MA).Google Scholar
• Russell GJ, Peterson A (2000) Analysis of cross category dependence in market basket selection. J. Retailing 76(3):367–392.Crossref, Google Scholar
• Russell GJ, Ratneshwar S, Shocker AD, Bell D, Bodapati A, Degeratu A, Hildebrandt L, Kim N, Ramaswami S, Shankar VH (1999) Multiple-category decision-making: Review and synthesis. Marketing Lett. 10(3):319–332.Crossref, Google Scholar
• Sahni N (2016) Advertising spillovers: Evidence from online field experiments and implications for returns on advertising. J. Marketing Res. 53(4):459–478.Crossref, Google Scholar
• Seetharaman PB, Chib S, Ainslie A, Boatwright P, Chan T, Gupta S, Mehta N, Rao V, Strijnev A (2005) Models of multi-category choice behavior. Marketing Lett. 16(3–4):239–254.Crossref, Google Scholar
• Shapiro B (2015) Positive spillovers and free riding in advertising of prescription pharmaceuticals: The case of antidepressants. Working paper, Massachusetts Institute of Technology, Cambridge.Google Scholar
• Song M, Nicholsony S, Lucarelliz C (2012) Bundling among rivals: A case of pharmaceutical cocktails. Working paper, University of Rochester, Rochester, NY.Google Scholar
• Sriram S, Chintagunta PK, Agarwal M (2010) Investigating consumer purchase behavior in related technology product categories. Marketing Sci. 29(2):291–314.Link, Google Scholar
• Stremersch S, Lemmens A (2009) Sales growth of new pharmaceuticals across the globe: The role of regulatory regimes. Marketing Sci. 28(4):690–708.Link, Google Scholar
• Stremersch S, Tellis GJ (2002) Strategic bundling of products and prices: A new synthesis for marketing. J. Marketing 66:55–72.Crossref, Google Scholar
• Stremersch S, Van Dyck W (2009) Marketing of the life sciences: A new framework and research agenda for a nascent field. J. Marketing 73:4–30.Crossref, Google Scholar
• Stremersch S, Landsman V, Venkataraman S (2013) The relationship between DTCA, drug requests, and prescriptions: Uncovering variation in specialty and space. Marketing Sci. 32(1):89–110.Link, Google Scholar
• Van Everdingen Y, Fok D, Stremersch S (2009) Modeling global spillover of new product takeoff. J. Marketing Res. 46(5):637–652.Crossref, Google Scholar
• Venkataraman S, Stremersch S (2007) The debate on influencing doctor’s decisions: Are drug characteristics the missing link? Management Sci. 53(11):1688–1701.Link, Google Scholar
• Venkatesh R, Mahajan V (1997) Products with branded components: An approach for premium pricing and partner selection. Marketing Sci. 16(2):146–165.Link, Google Scholar
• Wilbur KC (2008) How the digital video recorder changes traditional television advertising. J. Advertising 37(1):143–149.Crossref, Google Scholar